GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: GRA2 is reported to act as an inverse agonist of GPR21 [1].
|
|
|||||||||||||||||||||||||||||||||||
| Bioactivity Comments |
| Inhibits basal (constitutive) GPR21-mediated IP1 production in macrophages at μM concentrations [1]. |
| Targets where the ligand is described in the comment field | |
| Target | Comment |
| GPR21 | Positive benefit in models of diabetes/obesity [2,4] were not observed in another study [5]. A cryo-EM structure of unliganded GPR21 bound to G proteins has been reported [3]. GRA2 is reported as an inverse agonist [1]. |